InvestorsHub Logo
Followers 25
Posts 3482
Boards Moderated 0
Alias Born 08/21/2014

Re: None

Friday, 05/29/2015 5:43:08 AM

Friday, May 29, 2015 5:43:08 AM

Post# of 48316
Today is the first day of a new phase for Oncosec. A phase were the brutal market manipulation that comes with being OTC will be less significant. Let this be the beginning of an increased institutional base. Sure there will be darker days ahead but the best lay ahead.

Looking forward to seeing the combo trial with detailed protocol recruit its 1st patient. And the size of the trial in itself is not the goal. Keep in mind this is determined with the FDA. It has to be statidtically significant and prove that electroporated IL-12 will greatly enlarge the population that can be treated with Keytruda. Upon this hinges Oncosecs future.

As for dilution, our runway is over a year so it might happen. But a good biotech does it when it doesn't need too, from a position of strength. Lets wait and see what happens institutionally in the next couple of months.